SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 51.70
-0.20 (-0.39%)
Feb 2, 2026, 1:30 PM CST
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 6.2 billion as of February 2, 2026. Its market cap has decreased by -42.78% in one year.
Market Cap
6.20B
Enterprise Value
7.08B
Revenue
1.39B
Ranking
n/a
PE Ratio
53.98
Stock Price
51.70
Market Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 6.20B, an increase of 482.53%. That is a compound annual growth rate of 8.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.20B | 6.57% |
| Dec 31, 2025 | 5.82B | -46.25% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 13.04B |
| Handa Pharmaceuticals | 13.00B |
| Standard Chemical & Pharmaceutical | 10.92B |
| Formosa Laboratories | 6.91B |
| Orient Pharma | 6.44B |
| Easywell Biomedicals | 4.16B |
| Orient EuroPharma | 3.91B |
| Merdury Biopharmaceutical | 3.78B |